QT Imaging's Breast Acoustic CT(TM) scanner now available through national group purchasing agreement with Premier. Key Takeaway: QT Imaging Holdings, Inc. has announced that its Breast Acoustic CT(TM) scanner is now available through a national group purchasing agreement with Premier, Inc. This partnership, facilitated by NXC Imaging, aims to enhance the distribution of this innovative, radiation-free imaging technology for breast health management. The agreement is expected to improve accessibility for healthcare providers. Market sentiment analysis. Positive factors. * QT Imaging's Breast Acoustic CT(TM) scanner is now more accessible. * The agreement with Premier enhances distribution capabilities. * The technology is radiation-free, promoting safer breast health management. NOVATO, Calif.-(BUSINESS WIRE)-QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT(TM) scanner and provid Frequently asked questions. What is the Breast Acoustic CT(TM) scanner? The Breast Acoustic CT(TM) scanner is an innovative, radiation-free imaging technology designed for breast health management. Who is QT Imaging's distribution partner? QT Imaging's U.S. distribution partner is NXC Imaging, Inc., a subsidiary of Canon Medical Systems USA. What does the agreement with Premier entail? The agreement with Premier allows for national group purchasing of the Breast Acoustic CT(TM) scanner, improving its accessibility. Why is the scanner considered safer? The Breast Acoustic CT(TM) scanner is radiation-free, making it a safer option for breast imaging.

Tulavi Therapeutics has received a national group purchasing agreement and Breakthrough Technology Designation from Premier, Inc. for its allay™ Hydrogel Cap. Effective 15 September 2026, the agreement enables Premier members to access pre-negotiated pricing for the device, which is the first fully resorbable, in situ forming medical device designed to reduce symptomatic neuroma formation. Approximately 600,000 amputations and 1.9 million peripheral nerve surgeries are performed annually in the US. Neuromas, which can cause chronic pain, form when severed peripheral nerves heal erratically. The allay™ Hydrogel Cap is built on technology used in over 10 million patients worldwide. The sutureless device remains in place for approximately eight months, protecting nerves during the critical neuroma formation period.

Premier, Inc. announces executive appointments. Published on 09/21/2026 at 04:52 pm EDT S&P Capital IQ Premier, Inc. had appointed Florian Quarré as Chief AI and Analytics Officer. Quarré will lead Premier?s enterprise AI, data, analytics and technology strategy, including its new AI & Analytics Center of Excellence. His mandate is to accelerate Premier?s evolution into an AI-first organization, harnessing the collective power of Premier?s data and embedding intelligence into products, solutions and workflows that help members uncover opportunity, anticipate risk and improve clinical, operational and financial performance. Quarré brings more than 20 years of healthcare, AI and transformation experience. Most recently, he served as Senior Partner and Head of Digital Transformation at HealthScape Advisors following senior leadership roles at PwC, Ciox Health, ExponentialAI and Deloitte. Quarré is a frequent industry speaker and guest lecturer at Georgetown University. Premier, Inc. had appointed Matthew Zubiller, FACHE, as Chief Business and Product Officer. Zubiller will lead Premier?s product operations and enterprise strategy. He is responsible for identifying the most pressing needs facing healthcare providers, determining where Premier is uniquely positioned to solve them, and prioritizing investment in solutions that deliver measurable member and business value. Zubiller brings 30 years of experience leading healthcare, technology and services organizations, with deep expertise in product strategy, innovation, commercialization, revenue cycle and growth. Prior to joining Premier, he served as CEO and Board Member of Your Behavioral Health and CEO of e4health. He also previously held executive leadership roles at McKesson/Change Healthcare, AMN Healthcare and Smile Brands. (C) S&P Capital IQ - Business Wire - 2026